Literature DB >> 9166837

Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.

F Prosper1, K Vanoverbeke, D Stroncek, C M Verfaillie.   

Abstract

We have recently shown that more than 90% of long-term culture initiating cells (LTC-IC) mobilized in the peripheral blood (PB) of normal individuals express HLA-DR and CD38 antigens and can sustain hematopoiesis for only 5 weeks. However, 10% of LTC-IC in mobilized PB are CD34+ HLA-DR- and CD34+ CD38- and can sustain hematopoiesis for at least 8 weeks. We now examine the ex vivo expansion potential of CD34+ HLA-DR+ cells (rich in mature LTC-IC) and CD34+ HLA-DR- cells (rich in primitive LTC-IC) in granulocyte colony-stimulating factor (G-CSF) mobilized PB progenitor cells (PBPC). Cells were cultured in contact with M2-10B4 cells (contact) or in transwells above M2-10B4 (noncontact) without and with interleukin-3 (IL-3) and macrophage inflammatory protein (MIP-1alpha) for 2 and 5 weeks. Progeny were evaluated for the presence of colony-forming cells (CFC) and LTC-IC. When CD34+ HLA-DR+ PB cells were cultured in contact cultures without cytokines, a threefold expansion of CFC was seen at 2 weeks, but an 80% decrease in CFC was seen at week 5. Further, the recovery of LTC-IC at week 2 was only 17% and 1% at week 5. This confirms our previous observation that although CD34+ HLA-DR+ mobilized PB cells can initiate long-term cultures, they are relatively mature and cannot sustain long-term hematopoiesis. In contrast, when CD34+ HLA-DR- mobilized PB cells were cultured in contact cultures without cytokines, CFC expansion persisted until week 5 and 49% and 11% of LTC-IC were recovered at week 2 and 5, respectively. As we have shown for steady state bone marrow (BM) progenitors, recovery of LTC-IC was threefold higher when CD34+ HLA-DR- PBPC were cultured in noncontact rather than contact cultures, and improved further when IL-3 and MIP-1alpha were added to noncontact cultures (96 +/- 2% maintained at week 5). We conclude that although G-CSF mobilizes a large population of "mature" CD34+ HLA-DR+ LTC-IC with a limited proliferative capacity, primitive CD34+ HLA-DR- LTC-IC present in mobilized PB have similar characteristics as LTC-IC from steady state BM: (1) they can be maintained in noncontact cultures containing IL-3 and MIP-1alpha for at least 5 weeks; (2) they are subject to the same proliferation inhibitory influences of contact with stroma. Since the absolute number of primitive LTC-IC (week 8 LTC-IC) per mL of G-CSF mobilized PB is similar to that per mL of steady state BM, these studies further confirm that G-CSF mobilized PBPC may have similar long-term repopulating abilities as steady state BM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166837

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent.

Authors:  Liuyan Jiang; Sunny Malik; Mark Litzow; Dennis Gastineau; Ivana Micallef; Vivek Roy; Lawrence Solberg; Abba C Zubair
Journal:  Transfusion       Date:  2011-08-09       Impact factor: 3.157

2.  Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.

Authors:  Yanli Jin; Jingfeng Zhou; Fang Xu; Bei Jin; Lijing Cui; Yun Wang; Xin Du; Juan Li; Peng Li; Ruibao Ren; Jingxuan Pan
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

3.  Proteomic characterization of four subtypes of M2 macrophages derived from human THP-1 cells.

Authors:  Pengfei Li; Chen Ma; Jing Li; Shanshan You; Liuyi Dang; Jingyu Wu; Zhifang Hao; Jun Li; Yuan Zhi; Lin Chen; Shisheng Sun
Journal:  J Zhejiang Univ Sci B       Date:  2022-05-15       Impact factor: 5.552

4.  The human-sheep chimeras as a model for human stem cell mobilization and evaluation of hematopoietic grafts' potential.

Authors:  Graça Almeida-Porada; Christopher Porada; Nicole Gupta; Ali Torabi; David Thain; Esmail D Zanjani
Journal:  Exp Hematol       Date:  2007-10       Impact factor: 3.084

5.  CCL2 associated with CD38 expression during ex vivo expansion in human cord blood-derived hematopoietic stem cells.

Authors:  Chao-Ling Yao; Poyin Huang; Tsai-Chi Liu; Yung-Kai Lin; Ching-Yun Chen; Yi-Ting Lai; Tzu Yun Chin; Tsung-Yu Tseng; Yi-Chiung Hsu
Journal:  Aging (Albany NY)       Date:  2021-08-10       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.